Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study

Overview of attention for article published in Journal of Medical Genetics, November 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog

twitter: 4 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 13 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomized phase 3 BALANCE study

JMG Contact blog, 10 Nov 2023

BALANCE is the first study directly comparing pegunigalsidase alfa with agalsidase beta for the treatment of patients with…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.